Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Symbol
QNRX on Nasdaq
Shares outstanding
843,913
Price per share
$8.30
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
842,827
Total reported value
$12,161,983
% of total 13F portfolios
0%
Share change
+841,336
Value change
+$12,140,475
Number of holders
18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Stonepine Capital Management, LLC 11% +7% $47,201,973 +$3,465,711 3,271,100 +7.9% Stonepine Capital Management, LLC 29 Jan 2026
Woodline Partners LP 9.5% $38,298,838 2,785,370 Woodline Partners LP 31 Dec 2025
INTEGRATED CORE STRATEGIES (US) LLC 4.6% -49% $36,005,681 +$9,858,888 2,618,595 +38% Integrated Core Strategies (US) LLC 31 Dec 2025
ARMISTICE CAPITAL, LLC 5% $7,049,313 1,081,183 Armistice Capital, LLC 31 Mar 2025
Ikarian Capital, LLC 13% -50% $3,052,472 211,538 0% Ikarian Capital, LLC 31 Jan 2026
Aberdeen Group plc 8.9% $1,082,250 75,000 Aberdeen Group plc 31 Dec 2025
ADAR1 Capital Management, LLC 6.9% $483,309 58,230 ADAR1 Capital Management, LLC 31 Dec 2025
Resolute Capital Asset Partners LLC 8.5% $671,000 50,000 Resolute Capital Asset Partners LLC 10 Oct 2025

As of 31 Dec 2025, 18 institutional investors reported holding 842,827 shares of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX). This represents 100% of the company’s total 843,913 outstanding shares.

Top 18 Institutional Shareholders

The largest institutional shareholders of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) together control 100% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Ikarian Capital, LLC 25% 211,538 0.4% $3,052,493
Woodline Partners LP 9.4% 79,582 0% $1,148,368
Stonepine Capital Management, LLC 9.3% 78,189 0.9% $1,128,267
Aberdeen Group plc 8.9% 75,000 0% $1,082,250
MILLENNIUM MANAGEMENT LLC 8.9% 74,817 0% $1,079,609
SummitTX Capital, L.P. 7.7% 64,795 0.03% $934,992
BOOTHBAY FUND MANAGEMENT, LLC 7.1% 59,838 0.02% $863,462
ADAR1 Capital Management, LLC 6.9% 58,230 0.06% $840,259
AIGH Capital Management LLC 5.8% 49,323 0.21% $711,731
Resolute Capital Asset Partners LLC 3.6% 30,000 0.21% $432,900
Soleus Capital Management, L.P. 3% 25,000 0.02% $360,750
Simplify Asset Management Inc. 2.1% 17,448 0% $251,775
Centiva Capital, LP 1.4% 12,053 0.01% $173,925
MORGAN STANLEY 0.36% 3,000 0% $43,290
GAMMA Investing LLC 0.25% 2,084 +650% 0% $30,072
RHUMBLINE ADVISERS 0.2% 1,666 +38% 0% $24,031
SBI Securities Co., Ltd. 0.03% 247 +12250% 0% $3,564
UBS Group AG 0% 17 +1600% 0% $245

Institutional Holders of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 842,827 $12,161,983 +$12,140,475 $14.43 18
2025 Q3 1,491 $10,716 -$9,379 $7.09 4
2025 Q2 2,537 $23,400 +$22,428 $9.23 6
2025 Q1 108 $24 +$24 $0.22 1